These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9524089)

  • 1. In vitro study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors.
    Yamada M; Nakagawa H; Fukushima M; Shimizu K; Hayakawa T; Ikenaka K
    J Neurooncol; 1998 Apr; 37(2):115-21. PubMed ID: 9524089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Sep; 26(9):787-94. PubMed ID: 9757455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study.
    Nakagawa H; Yamada M; Fukushima M; Ikenaka K
    Cancer Chemother Pharmacol; 1999; 43(3):247-56. PubMed ID: 9923556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vivo study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) in meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Oct; 26(10):873-9. PubMed ID: 9789291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavitary chemotherapy with 5-fluoro-2'-deoxyuridine (FdUrd) in malignant brain tumors.
    Nakagawa H; Maeda N; Tsuzuki T; Suzuki T; Hirayama A; Miyahara E; Wada K
    Jpn J Clin Oncol; 2001 Jun; 31(6):251-8. PubMed ID: 11463802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
    Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
    Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugs.
    Shibamoto Y; Mimasu Y; Tachi Y; Hatta H; Nishimoto S
    J Chemother; 2002 Aug; 14(4):390-6. PubMed ID: 12420858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical application of FdUrd to meningeal dissemination of malignant tumors].
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Tsuzuki T; Hirayama A; Yamamoto H; Ikenaka K
    No Shinkei Geka; 1998 Nov; 26(11):969-77. PubMed ID: 9834491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
    Cao S; Frank C; Rustum YM
    J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.
    Murakami Y; Kazuno H; Emura T; Tsujimoto H; Suzuki N; Fukushima M
    Int J Oncol; 2000 Aug; 17(2):277-83. PubMed ID: 10891536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intrathecal administration of 5-fluoro-2'-deoxyuridine for the treatment of neoplastic meningitis.
    Nakagawa H; Miyahara E; Suzuki T; Wada K; Tamura M; Fukushima Y
    Neurosurgery; 2005 Aug; 57(2):266-80; discussion 266-80. PubMed ID: 16094155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
    Ashour OM; Naguib FN; Khalifa MM; Abdel-Raheem MH; Panzica RP; el Kouni MH
    Cancer Res; 1995 Mar; 55(5):1092-8. PubMed ID: 7866994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
    Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ
    World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
    Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
    Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
    van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
    Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer.
    van Laar JA; Rustum YM; Ackland SP; van Groeningen CJ; Peters GJ
    Eur J Cancer; 1998 Feb; 34(3):296-306. PubMed ID: 9640213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.